Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old

Completed

Conditions studied: AMH Levels, Inhibin B Levels, IVF Patients Over 38 Years Old

In brief

The present study is designed to evaluate the basal serum levels of anti-mullerian hormone (AMH) and inhibin B as early predictors of ovarian response, implantation rate, and pregnancy rate in women 38 years old or older that are undergoing an IVF cycle.

Key facts

Study ID

NCT01219387

Run by

Reproductive Medicine Associates of New Jersey

People needed

300

Starts

2006-02-01

Expected to finish

2010-06-01

Last updated by the study team

2013-01-23

Who can join

Age: 38 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women 38 years old or older at the time of initiating treatment

You may not qualify if…

• Uterine disease: malformation, septum, submucosal myomas, endometrial polyps Advanced endometriosis with endometrioma (s)
• No uterus
• Single ovary

Where it is running

• Reproductive Medicine Assoicates of New Jersey — Morristown, New Jersey, United States
• Reproductive Medicine Associates of PA at Lehigh Valley — Allentown, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.